Corticosteroid shots versus platelet-rich plasma shots for shoulder joint osteoarthritis
Compares corticosteroid and platelet-rich plasma injections for shoulder osteoarthritis in adults.
Key facts
- Who runs it
- Rush University Medical Center
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 13 Mar 2023
- Expected to end
- Jan 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Glenohumeral Injection
- Record updated
- 17 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with primary osteoarthritis of the shoulder joint and moderate or worse pain. It compares steroid injections with platelet-rich plasma (PRP) injections into the shoulder.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Primary glenohumeral (shoulder joint) arthritis, bone on bone or near bone on bone, diagnosed earlier on X-rays and by a doctor's exam. Pain level above 4 on the VAS pain scale.
- Earlier treatment
- No surgery on the same shoulder within 1 year. No injection into the shoulder joint within 3 months.
Main reasons for not taking part
- Arthritis from another cause, such as infection, rheumatoid arthritis, rotator cuff damage or injury
- Allergy to lidocaine
- Known pregnancy
- A workers compensation case about the shoulder
- Shoulder surgery on the same side within 1 year, or a shoulder joint injection within 3 months
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patient ≥18y.o. of age
- Primary glenohumeral arthritis (bone on bone or near bone on bone) that has been previously diagnosed on radiographs and clinical evaluation
- Baseline pain level of VAS >4
Who cannot take part
- Ipsilateral shoulder surgery within 1 year
- Allergy to lidocaine
- Secondary causes of arthritis (i.e. septic arthritis, rheumatoid arthritis, rotator cuff arthropathy, post-traumatic arthritis)
- Any glenohumeral joint injection within 3 months
- Known pregnancy
- Workers compensation case regarding shoulder
Where in United States
- Rush University Medical CenterChicago, United StatesContact: Carla M Edwards, PhDTaking people
About the trial
What the trial wants to find out
The purpose of this study is to compare the efficacy of intra-articular corticosteroid injections versus platelet-rich plasma injections for non-operative treatment of primary glenohumeral osteoarthritis. The efficacy of intra-articular injections, outside of hyaluronic acid, for the treatment of glenohumeral OA is not known, yet these treatments are commonly used with hopes of providing patients with symptomatic relief that can hopefully delay or prevent the need for shoulder arthroplasty. This study will help elucidate the therapeutic benefit of corticosteroid and Platelet Rich Plasma (PRP) injections in this patient population.
The 2 groups in the trial
- Corticosteroid Injection GroupTreatment being tested
80mg Depo-Medrol and 8cc Lidocaine ultrasound-guided intra-articular injection
Treatment: Glenohumeral Injection
- Platelet-Rich Plasma Injection GroupExisting treatment, for comparison
15cc blood draw in Arthrex Autologous Conditioned Plasma (ACP) kit and processed per manufacturer instructions Ultrasound-guided intra-articular injection of isolated PRP
Treatment: Glenohumeral Injection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective, Double Blind, Randomized Control Trial Comparing the Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis
- Plain-language title
- Corticosteroid shots versus platelet-rich plasma shots for shoulder joint osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 February 2026